Eagle Asset Management Inc. lessened its position in Phibro Animal Health Corp (NASDAQ:PAHC) by 5.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 277,820 shares of the company’s stock after selling 16,912 shares during the period. Eagle Asset Management Inc.’s holdings in Phibro Animal Health were worth $5,925,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Swiss National Bank boosted its holdings in shares of Phibro Animal Health by 2.4% during the 2nd quarter. Swiss National Bank now owns 37,800 shares of the company’s stock worth $1,201,000 after buying an additional 900 shares during the period. Allianz Asset Management GmbH raised its position in shares of Phibro Animal Health by 118.3% in the 2nd quarter. Allianz Asset Management GmbH now owns 50,211 shares of the company’s stock valued at $1,595,000 after buying an additional 27,207 shares in the last quarter. Pinebridge Investments L.P. raised its position in shares of Phibro Animal Health by 193.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 30,760 shares of the company’s stock valued at $978,000 after buying an additional 20,261 shares in the last quarter. Financial Gravity Wealth Inc. acquired a new position in shares of Phibro Animal Health in the 2nd quarter valued at approximately $38,000. Finally, Bank of America Corp DE raised its position in shares of Phibro Animal Health by 51.8% in the 2nd quarter. Bank of America Corp DE now owns 169,024 shares of the company’s stock valued at $5,370,000 after buying an additional 57,692 shares in the last quarter. 52.19% of the stock is owned by institutional investors.
In other Phibro Animal Health news, Director E Thomas Corcoran bought 5,000 shares of Phibro Animal Health stock in a transaction on Friday, August 30th. The shares were purchased at an average cost of $21.21 per share, with a total value of $106,050.00. Following the acquisition, the director now directly owns 15,000 shares of the company’s stock, valued at approximately $318,150. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 50.05% of the company’s stock.
Shares of Phibro Animal Health stock opened at $22.91 on Tuesday. The firm has a market capitalization of $936.08 million, a PE ratio of 14.97, a price-to-earnings-growth ratio of 6.53 and a beta of 0.87. The company has a current ratio of 3.21, a quick ratio of 1.77 and a debt-to-equity ratio of 1.84. The firm’s 50 day moving average is $22.09 and its 200 day moving average is $27.45. Phibro Animal Health Corp has a 1 year low of $20.00 and a 1 year high of $39.10.
Phibro Animal Health (NASDAQ:PAHC) last posted its earnings results on Monday, November 4th. The company reported $0.19 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.24 by ($0.05). Phibro Animal Health had a return on equity of 25.52% and a net margin of 4.99%. The business had revenue of $190.00 million for the quarter, compared to the consensus estimate of $199.22 million. During the same period in the previous year, the firm earned $0.39 earnings per share. The company’s revenue was down 5.0% compared to the same quarter last year. As a group, research analysts anticipate that Phibro Animal Health Corp will post 1.1 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.10%. The ex-dividend date is Tuesday, November 26th. Phibro Animal Health’s payout ratio is 31.37%.
Several equities analysts have recently commented on PAHC shares. Bank of America dropped their target price on shares of Phibro Animal Health from $29.00 to $18.00 and set an “underperform” rating for the company in a research report on Thursday, August 29th. BidaskClub raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Thursday, October 31st. Morgan Stanley raised shares of Phibro Animal Health from an “underweight” rating to an “equal” rating and lifted their price target for the company from $21.00 to $30.00 in a report on Thursday, September 5th. They noted that the move was a valuation call. ValuEngine raised shares of Phibro Animal Health from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, TheStreet lowered shares of Phibro Animal Health from a “b-” rating to a “c+” rating in a report on Tuesday, September 10th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $26.60.
Phibro Animal Health Profile
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture.
Recommended Story: How can you know how many shares are floating?
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Corp (NASDAQ:PAHC).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.